Sign up to save your podcasts
Or
Share Living Longer with Cancer: Rethinking Survivorship
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Living Longer with Cancer: Rethinking Survivorship
What comes after a cancer diagnosis and treatment?
In this episode of Science Will Win, host Dr. Raven Baxter explores one of the most important, and often overlooked, chapters for cancer patients: survivorship. As five-year survival rates climb to 70%, more people than ever are living with and beyond cancer. But longer survival brings its own complex challenges, and our care systems are still catching up.
You'll hear from experts and advocates working at the intersection of medicine, policy, and community. We’ll discuss what it really takes to support people through this transition — when the clinical benchmarks have passed and it’s time to go back to “normal life”.
From patient care plans and workplace disclosure to mental health, this episode makes one thing clear: survivorship demands dignity, support, and a whole new kind of care.
Featured guests:
– Tina Deignan, Commercial President, Pfizer Oncology
– Shelley Fuld Nasso, CEO, Cancer Nation
– Rebecca Nellis, Executive Director, Cancer and Careers
– Bob Riter, Breast Cancer Patient & Advocate
Dive into the episode here:
00:00 – The ongoing battle with cancer
03:43 – Rethinking survivorship
05:32 – The five-year survival myth
07:00 – The history of the term "survivor"
09:36 – Bob’s journey with breast cancer
11:38 – Lost in transition and survivorship care plans
14:25 – The intersection of cancer and work
18:49 – Rethinking how work gets done
20:00 – Disclosure and improving company culture
20:59 – The swivel technique
23:19 – Controlling your narrative
25:11 – Standardizing long-term survivorship care through policy
27:08 – Lack of access to care leads to disparities in survival rates
29:48 – Bob's second journey with cancer
32:21 – Takeaways and peek into our final episode
Check out our YouTube channel (@Pfizer) to watch the full interview with Raven & Bob Riter on his cancer journey.
Season 6 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter. It’s produced by Acast Creative Studios. Hosts in this podcast series were compensated for their time.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
View all episodes
By Pfizer
3.9
9292 ratings
What comes after a cancer diagnosis and treatment?
In this episode of Science Will Win, host Dr. Raven Baxter explores one of the most important, and often overlooked, chapters for cancer patients: survivorship. As five-year survival rates climb to 70%, more people than ever are living with and beyond cancer. But longer survival brings its own complex challenges, and our care systems are still catching up.
You'll hear from experts and advocates working at the intersection of medicine, policy, and community. We’ll discuss what it really takes to support people through this transition — when the clinical benchmarks have passed and it’s time to go back to “normal life”.
From patient care plans and workplace disclosure to mental health, this episode makes one thing clear: survivorship demands dignity, support, and a whole new kind of care.
Featured guests:
– Tina Deignan, Commercial President, Pfizer Oncology
– Shelley Fuld Nasso, CEO, Cancer Nation
– Rebecca Nellis, Executive Director, Cancer and Careers
– Bob Riter, Breast Cancer Patient & Advocate
Dive into the episode here:
00:00 – The ongoing battle with cancer
03:43 – Rethinking survivorship
05:32 – The five-year survival myth
07:00 – The history of the term "survivor"
09:36 – Bob’s journey with breast cancer
11:38 – Lost in transition and survivorship care plans
14:25 – The intersection of cancer and work
18:49 – Rethinking how work gets done
20:00 – Disclosure and improving company culture
20:59 – The swivel technique
23:19 – Controlling your narrative
25:11 – Standardizing long-term survivorship care through policy
27:08 – Lack of access to care leads to disparities in survival rates
29:48 – Bob's second journey with cancer
32:21 – Takeaways and peek into our final episode
Check out our YouTube channel (@Pfizer) to watch the full interview with Raven & Bob Riter on his cancer journey.
Season 6 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter. It’s produced by Acast Creative Studios. Hosts in this podcast series were compensated for their time.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
More shows like Science Will Win
View all
Stuff You Should Know
78,710 Listeners
Radiolab
43,826 Listeners
Pod Save America
87,983 Listeners
The Antigen
140 Listeners
Women's Health
27 Listeners
The Ancients
3,356 Listeners
Normal Gossip
5,820 Listeners
Breakthroughs
1 Listeners
Premonición
0 Listeners
Good Hang with Amy Poehler
12,381 Listeners
Pfizer Denmark
0 Listeners
Pfizer Australia
0 Listeners